A novel anti-IL4Rα nanoparticle efficiently controls lung inflammation during asthma

Drug resistance and the harmful side effects accompanying the prolonged corticosteroid treatment of chronic pulmonary diseases prompted the development of more specific anti-inflammatory approaches. Several strategies aiming to block IL4Rα, the receptor for a key pro-inflammatory pathway, were inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Halwani, Rabih, Sultana Shaik, Asma, Ratemi, Elaref, Afzal, Sibtain, Kenana, Rosan, Al-Muhsen, Saleh, Al Faraj, Achraf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099422/
https://www.ncbi.nlm.nih.gov/pubmed/27713399
http://dx.doi.org/10.1038/emm.2016.89

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099422/
https://www.ncbi.nlm.nih.gov/pubmed/27713399
http://dx.doi.org/10.1038/emm.2016.89

Ejemplares similares